SEMAGLUTIDE

semaglutide 1.34 mg/mL injection, 1 x 3 mL pen device

SEMAGLUTIDE (15322K)

semaglutide 1.34 mg/mL injection, 1 x 3 mL pen device
15322K
Body System:
Manner of administration:Injection
General Schedule
Authority Required (STREAMLINED)

Restriction  18495

Indication: Diabetes mellitus type 2
Treatment phase: Subsequent PBS-prescriptions for any GLP-1 receptor agonist
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $260.42 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Ozempic